This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Excessive and redundant skin and subcutaneous tissue
L12_EXCESSSKINDANDSUBCUTIS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Excessive and redundant skin and subcutaneous tissue
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 49 | 48 | - |
| Only index persons | 49 | 48 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | - |
| Only index persons | 0.00 | 0.00 | - |
| Median age at first event (years) | |||
| Whole population | - | 51.65 | - |
| Only index persons | 51.20 | 51.65 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 31 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 57.96 | 59.60 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
28
142
7.38
5.37
11.9
7.0
umol/l
11.1
10.1
0.25
28
131
(3044640) Blood type and Crossmatch panel - Blood
21
86
4.97
4.79
2.8
2.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
8
9
11.25
4.57
4.1
4.2
u/ml
13.3
98.4
—
8
9
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
7
6
14.29
4.50
2.0
2.8
%
38.5
25.6
—
7
6
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
19
75
4.61
4.48
3.0
3.2
ng/l
12.0
23.1
1.34
14
44
(3000330) Specific gravity of Urine by Test strip
8
11
9.16
4.13
4.5
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
22
110
4.00
3.51
5.0
3.7
g/l
36.4
36.3
0.03
22
104
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
7
10.12
3.41
1.8
2.3
mmol/l
26.5
25.6
—
6
7
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
19
89
3.67
3.28
3.9
2.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
8
18
5.50
3.02
1.6
5.6
kpa
5.7
6.0
—
8
18
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
23
128
3.63
2.94
5.0
3.8
—
—
—
0
0
(3013512) EKG study
14
58
3.46
2.84
6.8
3.4
—
—
—
0
0
(3012544) pH of Venous blood
8
20
4.92
2.78
1.6
5.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
20
4.92
2.78
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
12
5.84
2.52
2.2
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
17
4.92
2.51
1.1
1.0
—
—
—
0
0
(4035726)
8
23
4.24
2.46
1.3
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
14
63
3.12
2.43
5.1
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
28
198
3.72
2.35
6.1
3.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
33
275
+∞
2.33
20.2
12.2
mmol/l
140.2
139.9
0.46
33
264
(3004789) Transferrin [Mass/volume] in Serum or Plasma
9
32
3.48
2.21
1.9
2.4
g/l
2.3
2.4
—
9
27
(3023103) Potassium [Moles/volume] in Serum or Plasma
33
276
+∞
2.10
20.4
12.4
mmol/l
3.9
3.9
0.95
33
264
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
21
3.94
2.10
2.4
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
33
282
+∞
1.89
23.4
11.9
mg/l
17.3
22.8
0.60
27
213
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
8
30
3.19
1.87
2.0
2.6
%
30.1
24.1
—
8
25
(3007164) IgA [Mass/volume] in Serum or Plasma
14
72
2.64
1.83
1.4
1.4
g/l
1.8
2.3
—
7
47
(3003327) Ova and parasites identified in Stool by Light microscopy
5
14
4.01
1.68
1.6
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
37
2.96
1.64
2.1
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
16
92
2.43
1.63
9.6
3.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
9
39
2.79
1.59
4.4
2.2
ug/g
54.6
83.8
—
9
30
(40761535) Cells panel - Urine sediment
5
15
3.73
1.58
5.4
4.1
—
—
—
0
0
(3044889) 12 lead EKG panel
25
183
2.50
1.57
3.9
3.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
33
290
+∞
1.44
29.2
13.4
umol/l
67.0
69.3
0.41
33
290
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
64
2.38
1.40
2.9
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
11
57
2.39
1.36
1.8
1.5
nmol/l
18.9
22.5
0.51
11
45
(40768804) Tissue Pathology biopsy report
19
126
2.20
1.32
2.4
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8
38
2.45
1.29
1.8
1.4
—
—
—
0
0
(3015736) pH of Urine
17
109
2.15
1.28
6.4
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
13
75
2.21
1.26
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
13
75
2.21
1.26
4.3
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
33
297
+∞
1.24
23.4
9.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
32
2.50
1.16
1.6
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
22
2.49
1.07
2.2
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
27
2.49
0.99
4.0
5.9
—
—
—
0
0
(3002256) Pathology report gross observation
8
42
2.19
0.98
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
66
2.00
0.93
1.5
2.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
16
114
1.78
0.79
4.2
5.3
mmol/l
1.2
1.2
0.01
16
104
(40768797) Stomach Pathology biopsy report
7
40
1.95
0.77
1.3
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
26
2.08
0.74
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
5
26
2.08
0.74
6.4
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
63
1.84
0.72
5.6
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
29
1.85
0.66
1.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
12
82
1.73
0.66
10.9
8.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
28
248
1.85
0.54
25.8
15.5
g/l
331.4
331.3
0.01
28
248
(3041096) Erythrocytes [Presence] in Urine by Automated
11
81
1.54
0.43
6.3
3.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
34
1.55
0.42
3.0
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
69
1.42
0.42
8.7
5.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
43
1.48
0.37
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
13
105
1.39
0.31
7.5
3.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
107
1.35
0.27
5.5
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
12
100
1.31
0.22
5.3
2.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
33
316
+∞
0.20
36.4
17.4
pg
30.0
30.2
0.21
33
310
(3024731) MCV [Entitic volume]
33
316
+∞
0.20
36.6
17.4
fl
90.7
90.8
0.05
33
310
(3026361) Erythrocytes [#/volume] in Blood
33
316
+∞
0.20
36.8
17.5
e12/l
4.5
4.5
0.01
33
307
(3000963) Hemoglobin [Mass/volume] in Blood
33
316
+∞
0.20
36.9
17.5
g/l
133.1
133.8
0.12
33
310
(3010813) Leukocytes [#/volume] in Blood
33
316
+∞
0.20
36.9
17.5
e9/l
6.7
6.4
0.39
33
307
(3007461) Platelets [#/volume] in Blood
33
316
+∞
0.20
36.7
17.5
e9/l
269.8
263.7
0.18
33
309
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
59
1.24
0.20
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
76
1.25
0.18
1.1
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
224
1.26
0.16
2.6
3.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
6
0.00
0.00
0.0
4.3
—
107.7
—
0
6
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
99.0
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
4.0
—
1.1
—
0
6
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020891) Body temperature
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3039000) Anion gap in Blood
0
6
0.00
0.00
0.0
4.3
—
10.8
—
0
6
(4094501)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
8.1
—
0
5
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
69
1.02
0.00
1.7
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_EXCESSSKINDANDSUBCUTIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_EXCESSSKINDANDSUBCUTIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_EXCESSSKINDANDSUBCUTIS – Excessive and redundant skin and subcutaneous tissue
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data